Stereotactic intensity modulated radiotherapy after radical prostatectomy (SCIMITAR): Two-year quality of life and toxicity outcomes of a multicenter phase II trial.

Authors :: Nikitas, John
Ballas, Leslie K.
Franco, Antonio
Lynch, Connor
Ma, Ting Martin
Valle, Luca Faustino
Romero, Tahmineh
Sachdeva, Ankush
Chong, Natalie
Basehart, Vincent
Reiter, Robert Evan
Saigal, Christopher
Chamie, Karim
Litwin, Mark S.
Rettig, Matthew
Nickols, Nicholas George
Steinberg, Michael L.
Cao, Minsong
Liauw, Stanley L.
Kishan, Amar Upadhyaya
Source :: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p317-317, 97p
Publication Year :: 2024

Full Text Access

Tools